| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.029 | 60.563 | 68.417 | 68.811 | 82.495 | 104.769 | 120.680 | 132.050 | 137.040 | 168.394 |
| Total Income - EUR | 52.949 | 60.734 | 70.966 | 69.893 | 90.844 | 104.967 | 121.128 | 134.629 | 137.592 | 168.427 |
| Total Expenses - EUR | 37.222 | 76.710 | 69.746 | 74.185 | 85.492 | 95.286 | 111.279 | 125.678 | 131.003 | 165.082 |
| Gross Profit/Loss - EUR | 15.727 | -15.976 | 1.220 | -4.292 | 5.351 | 9.681 | 9.849 | 8.950 | 6.589 | 3.345 |
| Net Profit/Loss - EUR | 14.138 | -17.191 | 510 | -4.991 | 4.443 | 8.631 | 8.638 | 7.676 | 5.213 | 677 |
| Employees | 1 | 2 | 3 | 3 | 2 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Pharmacob Viva Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 10.425 | 8.256 | 6.428 | 4.660 | 2.959 | 0 | 0 | 0 | 0 |
| Current Assets | 38.351 | 20.121 | 18.826 | 18.542 | 18.088 | 20.705 | 32.691 | 38.076 | 42.025 | 39.169 |
| Inventories | 24.519 | 7.959 | 7.146 | 5.350 | 5.582 | 7.135 | 7.941 | 8.595 | 9.402 | 10.826 |
| Receivables | 5.639 | 3.276 | 9.300 | 11.604 | 10.526 | 10.628 | 20.281 | 21.302 | 20.412 | 17.739 |
| Cash | 8.192 | 8.887 | 2.381 | 1.588 | 1.980 | 2.942 | 4.469 | 8.180 | 12.211 | 10.591 |
| Shareholders Funds | -1.042 | -18.222 | -17.404 | -22.075 | -17.205 | -8.248 | 573 | 8.251 | 13.439 | 4.208 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 39.393 | 48.969 | 44.682 | 47.239 | 40.080 | 31.912 | 32.118 | 29.826 | 28.587 | 34.961 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmacob Viva Srl